Mougeot, J.-L.; Beckman, M.; Kooshki, M.; Neuberger, J.; Shukla, K.; Furdui, C.; Bahrani Mougeot, F.; Porosnicu, M.
Salivary Microbiome Profiling of HPV+ and HPV− Oropharyngeal Head and Neck Cancer Patients Undergoing Durvalumab Immunotherapy Suggests Prevotella melaninogenica and Veillonella atypica as Key Players: A Pilot Study. Cancers 2025, 17, 452.
https://doi.org/10.3390/cancers17030452
AMA Style
Mougeot J-L, Beckman M, Kooshki M, Neuberger J, Shukla K, Furdui C, Bahrani Mougeot F, Porosnicu M.
Salivary Microbiome Profiling of HPV+ and HPV− Oropharyngeal Head and Neck Cancer Patients Undergoing Durvalumab Immunotherapy Suggests Prevotella melaninogenica and Veillonella atypica as Key Players: A Pilot Study. Cancers. 2025; 17(3):452.
https://doi.org/10.3390/cancers17030452
Chicago/Turabian Style
Mougeot, Jean-Luc, Micaela Beckman, Mitra Kooshki, Justin Neuberger, Kirtikar Shukla, Cristina Furdui, Farah Bahrani Mougeot, and Mercedes Porosnicu.
2025. "Salivary Microbiome Profiling of HPV+ and HPV− Oropharyngeal Head and Neck Cancer Patients Undergoing Durvalumab Immunotherapy Suggests Prevotella melaninogenica and Veillonella atypica as Key Players: A Pilot Study" Cancers 17, no. 3: 452.
https://doi.org/10.3390/cancers17030452
APA Style
Mougeot, J.-L., Beckman, M., Kooshki, M., Neuberger, J., Shukla, K., Furdui, C., Bahrani Mougeot, F., & Porosnicu, M.
(2025). Salivary Microbiome Profiling of HPV+ and HPV− Oropharyngeal Head and Neck Cancer Patients Undergoing Durvalumab Immunotherapy Suggests Prevotella melaninogenica and Veillonella atypica as Key Players: A Pilot Study. Cancers, 17(3), 452.
https://doi.org/10.3390/cancers17030452
